Zack Armen | executive |
Jennifer Buell | executive |
Marcus van Dijk | executive |
Christine Klaskin | executive |
Emily Bodnar | analyst |
Jack Allen | analyst |
Mayank Mamtani | analyst |
Good day, everyone, and welcome to the MiNK Therapeutics Fourth Quarter 2023 Financial Results. Today's call is being recorded. [Operator Instructions] I would now like to turn the conference over to Zack Armen, Head of Investor Relations. Please go ahead.
Thank you, Lisa, and thank you all for joining us today.